After an impressive performance last year, biotech stocks are having a less than stellar 2021. The iShares Biotechnology ETF (IBB) currently only up 4.5% year to date (YTD), compared to the 21% gain for the ...
Protagonist Therapeutics Inc. (PTGX) and TCR2 Therapeutics Inc. (TCRR) have plunged in the past week, after disappointing results of their respective clinical trials. The news has created bearish momentum for each stock that is unlikely ...
You are now leaving a Magnifi Communities' website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.
Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.